The Lubkin Fund for MHE Research
A nonprofit fundraiser supporting
The Philadelphia Foundation
Finding a treatment and eventual cure for Multiple Hereditary Exostoses, a rare and debilitating bone disorder.
$2,419
raised by 18 people
About the Fund
The Lubkin Fund for MHE Research was established to provide initial funding into the basic science and applied molecular and cellular research of Multiple Hereditary Exostoses (MHE). The goal is to expand successful projects with funding from larger and more traditional grant sources, such as the NIH’s Office of Rare Diseases.
MHE is an autosomal dominant bone disorder characterized by the growth of numerous cartilage-capped bony tumors. Secondary symptoms include abnormal bone growth, progressive skeletal deformity, and chronic pain. As there is currently no cure or pharmaceutical treatment, invasive surgery is the only option to manage pain and long-term function.
The Lubkin Fund for MHE Research is focused on the interplay of EXT genetics with glycobiology cell signaling in an effort to develop the first generation of drugs to attack the disease at its genetic source. For more background on the science and manifestations of MHE please visit our website listed below.
News
Ben's ride for MHE research was the fund's inaugural fundraiser. Read the Journal News Story about the ride: http://lubkinfundmhe.org/uploads/Journal_News_Article_June_28_Ben.pdf.
Contact Us
email: Directors@LubkinFundMHE.org
website: www.lubkinfundmhe.org